Literature DB >> 1766680

Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice.

P A Burns1, C J Kemp, J V Gannon, D P Lane, R Bremner, A Balmain.   

Abstract

Functional alterations or loss of tumor-suppressor genes are an important feature of neoplastic progression in humans. The employment of suitable animal model systems would greatly facilitate the detection and manipulation of such genes. We describe here an experimental approach to this problem based on the analysis of skin tumors induced in F1 hybrids between Mus musculus and Mus spretus mice. The results show that loss of heterozygosity on chromosome 11 occurred in 4/13 mouse skin carcinomas, but not in premalignant papillomas. Since the murine p53 gene is located on this chromosome, immunoprecipitation and DNA-sequencing studies were carried out on tumorigenic cell lines and primary tumor DNA respectively to determine the status of p53 alleles. These studies revealed the presence of p53 mutations, both frameshifts and missense, some of which are identical to those found in human tumors. Loss of normal p53 function is found in well-differentiated squamous-cell carcinomas and thus does not appear to be directly responsible for further progression to an undifferentiated spindle cell phenotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766680

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Comparative hepatocellular cancer genetics.

Authors:  C J Kemp
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.

Authors:  Samy Lamouille; Erin Connolly; James W Smyth; Rosemary J Akhurst; Rik Derynck
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

3.  Linkage analysis of 84 microsatellite markers in intra- and interspecific backcrosses.

Authors:  M A McAleer; T J Aitman; R J Cornall; S Ghosh; J R Hall; C M Hearne; J M Love; J B Prins; S Ramachandran; N Rodrigues
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

4.  Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.

Authors:  Erin C Connolly; Elise F Saunier; David Quigley; Minh Thu Luu; Angela De Sapio; Byron Hann; Jonathan M Yingling; Rosemary J Akhurst
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

Review 5.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

6.  Productive replication of human adenoviruses in mouse epidermal cells.

Authors:  I Ganly; V Mautner; A Balmain
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.

Authors:  A Glick; N Popescu; V Alexander; H Ueno; E Bottinger; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

8.  Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes.

Authors:  R W Wiseman; C Cochran; W Dietrich; E S Lander; P Söderkvist
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 9.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

10.  Tumor suppression by p53 in the absence of Atm.

Authors:  S Lawrence Bailey; Kay E Gurley; Kyung Hoon-Kim; Karen S Kelly-Spratt; Christopher J Kemp
Journal:  Mol Cancer Res       Date:  2008-06-26       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.